Anthropic Is Expected to Go Public in October. The Brokerages Get Paid Either Way.

Goldman Sachs and Morgan Stanley are reportedly lead advisors on Anthropic's potential October IPO, which could raise up to $100 billion at a projected $2 trillion valuation. The article cites $100 million in fees earned by each bank on the prior SpaceX IPO and argues Anthropic could generate comparable or higher advisory fees. Goldman has fallen 15% from its July high to $976 and Morgan Stanley 10% to $206, while cited median price targets imply 23% and 20% upside, respectively.

Analysis

The direct underwriting economics are not large enough to alter FY earnings estimates for GS or MS; the investable signal is whether this transaction reopens a broader late-stage technology issuance pipeline. GS has greater operating leverage to a sustained revival in advisory, equity underwriting, derivatives and sponsor-financing activity, while MS’s wealth platform makes its earnings response less cyclical but creates a potentially underappreciated distribution benefit if client allocations into private/IPO-linked products accelerate. BAC, JPM, C and BCS could capture meaningful ancillary lending, hedging and secondary-trading revenues even without lead-left economics.

Near-term upside is likely driven by mandate headlines and pre-deal positioning, but the 1-3 month catalyst is a successful bookbuild followed by evidence that other AI/private-market issuers pull forward listings. The key risk is that a high-profile deal absorbs institutional risk capacity, widens IPO discounts, and crowds out the broader calendar; in that case, a large headline transaction is a one-off rather than proof of a durable fee-cycle inflection. The article's fee and valuation assertions should be treated as unverified until prospectus, syndicate and pricing details are available.

Contrarian view: the market may be over-attributing bank share-price performance to a single mandate when rates, trading conditions, credit marks and capital-return expectations remain much larger earnings drivers. A weak aftermarket performance would hurt sentiment toward AI issuance but could benefit incumbent banks' trading desks through volatility and hedging volumes; it would be more damaging to high-beta private-market proxies than to diversified universal banks.

Key Decisions for Investors

• Prefer a 3-6 month long GS / short MS pair only if GS trades at a discount to its recent relative valuation range: GS offers higher upside to a genuine underwriting and M&A-cycle acceleration, while the short leg reduces broad financial-sector and equity-market beta. Exit if GS global-banking backlog or forward fee guidance fails to improve at the next earnings release.
• Maintain JPM as the higher-quality liquid alternative rather than chase lead-advisor headlines: its balance-sheet, payments and markets mix can monetize financing and hedging around an issuance wave with lower dependence on one deal. Reassess if capital-markets fee growth decelerates sequentially despite a stronger IPO calendar.
• Do not initiate a standalone long in BAC, C or BCS on this catalyst alone; use a confirmed expansion in announced U.S. IPO proceeds and secondary issuance over the next 4-8 weeks as the trigger for broader capital-markets exposure.
• Set an event alert for formal filing, indicated price range, cornerstone demand and first-week aftermarket performance. A materially upsized deal with tight pricing supports adding GS exposure; a discounted pricing range or trading below issue would falsify the near-term fee-cycle re-rating thesis.